These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 9129655
1. The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells. Mlynar E, Bevec D, Billich A, Rosenwirth B, Steinkasserer A. J Gen Virol; 1997 Apr; 78 ( Pt 4)():825-35. PubMed ID: 9129655 [Abstract] [Full Text] [Related]
2. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions. Billich A, Hammerschmid F, Peichl P, Wenger R, Zenke G, Quesniaux V, Rosenwirth B. J Virol; 1995 Apr; 69(4):2451-61. PubMed ID: 7884893 [Abstract] [Full Text] [Related]
3. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E. J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548 [Abstract] [Full Text] [Related]
4. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. Dorfman T, Göttlinger HG. J Virol; 1996 Sep; 70(9):5751-7. PubMed ID: 8709190 [Abstract] [Full Text] [Related]
11. Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle. Daelemans D, Dumont JM, Rosenwirth B, De Clercq E, Pannecouque C. Antiviral Res; 2010 Feb; 85(2):418-21. PubMed ID: 19857522 [Abstract] [Full Text] [Related]
12. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies. BouHamdan M, Kulkosky J, Duan LX, Pomerantz RJ. J Hum Virol; 2000 Feb; 3(1):6-15. PubMed ID: 10774802 [Abstract] [Full Text] [Related]
13. Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. Sokolskaja E, Olivari S, Zufferey M, Strambio-De-Castillia C, Pizzato M, Luban J. J Virol; 2010 May; 84(9):4851-5. PubMed ID: 20181694 [Abstract] [Full Text] [Related]
14. Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Chen S, Zhao X, Tan J, Lu H, Qi Z, Huang Q, Zeng X, Zhang M, Jiang S, Jiang H, Yu L. Eur J Pharmacol; 2007 Jun 22; 565(1-3):54-9. PubMed ID: 17449029 [Abstract] [Full Text] [Related]
15. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. Braaten D, Franke EK, Luban J. J Virol; 1996 Jul 22; 70(7):4220-7. PubMed ID: 8676442 [Abstract] [Full Text] [Related]
17. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. Braaten D, Luban J. EMBO J; 2001 Mar 15; 20(6):1300-9. PubMed ID: 11250896 [Abstract] [Full Text] [Related]